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cellular immune response is not limited to
intracellular infections. In agreement with these
results, a number of Gram-negative and Gram-
positive bacteria are capable of inducing IP-10 and
Mig release in human whole blood in vitro [15].
To our knowledge, this is the ﬁrst study in
which the circulating levels of GrA, GrB, IP-10
and Mig have been studied in a large series of
patients with leptospirosis. The observation of
elevated levels of GrB, IP-10 and Mig in these
patients suggests that activation of a cellular
immune response is part of the early host defence
against Leptospira.
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ABSTRACT
This ad-hoc observational study, conducted in the
metropolitan area of Berlin during 2004, revealed
that the prevalence of Chlamydia trachomatis (CT)
infections in female urban adolescents self-pre-
senting at their gynaecologist without (n = 397) or
with (n = 124) symptoms of CT infection was
5.5% (95% CI 3.7–8.2%) and 9.7% (95% CI 5.6–
16.2%), respectively. The prevalence of CT infec-
tion was signiﬁcantly dependent on the number
Corresponding author and reprint requests: G. Griesinger,
Universita¨tsklinikum Schleswig-Holstein, Campus Luebeck,
Department of Obstetrics and Gynecology, Ratzeburger Allee
160, 23538 Luebeck, Germany
E-mail: georg.griesinger@frauenklinik.uni-luebeck.de
436 Clinical Microbiology and Infection, Volume 13 Number 4, April 2007
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 430–456
of lifetime sexual partners. Condom use was
inconsistent, and lack of knowledge about CT
infections and associated health risks predomin-
ated in this cohort. The data indicated a need for
health education concerning CT to be targeted at
female adolescents.
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Chlamydia trachomatis (CT) infection is a common
sexually transmitted disease in industrialised
countries [1,2]. CT infections often remain
asymptomatic, and therefore undetected. Pelvic
inﬂammatory disease, with subsequent tubal
factor infertility and ectopic pregnancy, are
linked to CT [3–5]. It has been suggested that
CT, together with Neisseria gonorrhoeae, is the
most common cause of tubal factor infertility [6],
and that CT, when manifest in pregnancy, can
cause serious complications in both offspring
and mothers [7].
Previous studies have indicated that know-
ledge concerning most common sexually trans-
mitted diseases is generally low among sexually
active European women [8–12]. Combined with a
secular trend towards earlier sexual initiation, an
increase in the number of lifetime sexual partners,
and inconsistent use of condoms among teen-
agers, this means that adolescents are therefore at
risk of acquiring CT infection [9,13,14]. No man-
datory notiﬁcation of CT infection exists in
Germany, and no data from ad-hoc prevalence
studies in young women are available. The aim
of the present study was therefore to evaluate
sexual behaviour and condom use, together with
the prevalence of CT infection, in a high-risk
population.
In a prospective ad-hoc observational study in
the metropolitan area of Berlin, 30 gynaecologists
and one outpatient department of a tertiary
referral clinic (University Clinic of Obstetrics
and Gynaecology, Campus Virchow, Berlin)
offered screening for CT between January and
June 2004, without cost to the patient, to
women aged £20 years with a history of sexual
intercourse on at least one occasion, who were
seeking medical advice for a variety of reasons
(asymptomatic women are normally liable to
meet the costs of CT screening in Germany).
Women who were unable to provide the
necessary information because of language
problems were excluded. Two groups were
deﬁned prospectively: group I comprised women
seeking medical advice for reasons including
prescription of contraceptives, cycle irregularities,
and exclusion of pregnancy, who were asympto-
matic of a vaginal or cervical infection; and group
II comprised women who presented with one or
more of the following symptoms: abdominal pain,
vaginal discharge, vaginal itching, burning, dysu-
ria or dysmenorrhoea. Allocation to groups was
according to the symptoms described by the
patient. The number of women who refused CT
testing was not recorded. Written informed
consent and administrative approval by the
ofﬁcer for data protection of the state of Berlin
was obtained.
Endocervical scrapes were collected with cervix
brushes placed in Amplicor medium (Roche
Molecular Diagnostics, Mannheim, Germany)
and were anonymised by number coding. Each
patient completed a simple, partly tick-style,
questionnaire, with the ﬁrst section requesting
data concerning demographics and contraceptive
use, and the second section exploring the partic-
ipants’ knowledge regarding CT. The question-
naire was sealed by the patient in an opaque
envelope.
CT testing was performed centrally using the
COBAS Amplicor Chlamydia trachomatis detection
kit (Roche Molecular Diagnostics), which has a
sensitivity and speciﬁcity of 91% and 98%,
respectively, with endocervical samples. All pos-
itive results were reported back to the original
gynaecologist, who then took responsibility for
prescribing treatment and further management.
Questionnaires were collected together with the
specimen, and were then checked for plausibility
and evaluated centrally. It was calculated that a
sample size of 520 would produce a 95% CI equal
to the sample proportion ± 2.5% with an estima-
ted prevalence of CT infection in the population
of 10%.
In total, 521 participants (91.9% native German
speakers) were recruited to the study, of whom
397 were asymptomatic for CT infection, and 124
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were symptomatic for CT infection. The mean age
was 17.5 ± 1.6 (range 14–20) years and 17%, 36%
and 47% had a low, intermediate and high level
of education, respectively. The mean overall age
at ﬁrst sexual intercourse was 15.2 ± 1.5 years,
giving a mean exposure time of 26 months. The
mean number of lifetime sexual partners was
3.5 ± 4 per participant, with 35.1% having had
one partner, and 7% having had ten or more
previous sexual partners. In the 12-month period
preceding assessment, a mean of 1.7 ± 1.5 part-
ners was reported.
Knowledge concerning CT was poor, with
80.8% of participants reporting no previous
knowledge of CT or adverse health consequences,
e.g., tubal infertility (Table 1). Condom use
decreased signiﬁcantly from ﬁrst to latest sexual
intercourse. Inversely, use of oral contraceptive
pills increased (data not shown). The majority of
the study participants used condoms only occa-
sionally. The prevalence of CT infection was 6.5%
(95% CI 4.7–9.0%). In asymptomatic patients, the
prevalence was 5.5% (95% CI 3.7–8.2%), and in
symptomatic patients it was 9.7% (95% CI 5.6–
16.2%). The prevalence of CT increased signiﬁ-
cantly with the number of lifetime sexual partners
(Fig. 1). No association between CT prevalence
and age, educational level, previous knowledge
about CT or condom use was found (data not
shown).
In Germany, a recent ad-hoc prevalence study
[15] reported a CT prevalence of 7.7% in young
adults aged 20–24 years. In other European coun-
tries, an increase in the prevalence of CT was
observed during the late 1990s, with the highest
prevalence rates in young women [16–18]. Svens-
son et al. [19] used antigen immunoassay testing
of urine samples to reveal a CT prevalence of
2.1% among Swedish high school students aged
<20 years during 1991–1992. Similarly, Kirkwood
et al. [20] used a ligase chain reaction to reveal
a prevalence rate of 6.2% in urine samples
from women aged <20 years who presented at
family planning clinics in the UK during 1996–
1997.
It should be stressed that CT prevalence results
from the endocervical samples taken in the
present study cannot be extrapolated to the
general population, as only young, sexually active
women who were actively seeking healthcare
were assessed. Furthermore, demographics,
sexual habits and socio-economic backgrounds
probably differ between an urban population and
the overall adolescent population. However, the
ideal population-based approach is difﬁcult to
achieve with endocervical samples, for obvious
reasons. An important methodological drawback
of the study was that response rates were not
recorded; however, they were estimated by the
participating gynaecologists to range between
90% and 95%, thus making a ‘healthy volunteer
effect’ of large magnitude unlikely. The present
data clearly suggest that education concerning
CT and the prevention of CT infection needs to
be improved for female adolescents, and that at
least opportunistic screening of female adoles-
cents engaged in sexual activity appears to be
warranted.
Table 1. Knowledge concerning Chlamydia trachomatis
(CT), use of condoms and attitude towards condom use
Study
population
(n = 521)
(%)
Previous knowledge that
CT exists 19.2
CT infections are often asymptomatic 13.4
CT can cause infertility 13.4
CT prevalence is estimated at c. 10% in sexually active women 6.0
Condoms
Used at ﬁrst sexual intercourse 65.3
Used at latest sexual intercourse 21.3
Currently never used 28.3
Currently exclusively used 17.2
Currently occasionally used 52.7
I agree that
‘Condoms are uncool’ 10.4
‘Sex is better without condoms’ 50.7
‘Condoms should always be used’ 45.5
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Fig. 1. Prevalence of Chlamydia trachomatis (CT), showing
95% CIs, according to the number of lifetime sexual
partners (sample size 521; p 0.03; chi-square for trend).
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ABSTRACT
Haemophilus inﬂuenzae is an uncommon cause of
bacterial meningitis in adults. This report des-
cribes a prospective evaluation of 16 episodes of
community-acquired H. inﬂuenzae meningitis in a
nationwide study on bacterial meningitis. Predis-
posing conditions were present in eight (50%) of
the 16 episodes; the most common predisposing
conditions were otitis or sinusitis (ﬁve episodes;
31%) and remote neurosurgery or head trauma
(three episodes; 19%). One (6%) episode was fatal
and hearing loss occurred in four (25%) episodes.
It was concluded that H. inﬂuenzae meningitis in
adults is a disease with a rather benign clinical
course and a relatively good prognosis compared
with pneumococcal meningitis.
Keywords Adults, bacterial meningitis, community-
acquired Haemophilus inﬂuenzae, hearing impairment,
meningitis
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